The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Shire plc

19 Dec 2018 15:35

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Millennium International Management LP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Shire plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18th December 2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

Yes, Takeda Pharmaceutical Company Limited

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: 5p ordinary (JE00B2QKY057) - interest [partially] held via holding of ADRs and ADR Options (US82481R1068)

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 4,712,865 0.514% 244,500 0.027%
(2) Cash-settled derivatives: 3,576,304 0.390% 0 0.000%
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 910,000 0.099% 240,000 0.026%

TOTAL:

9,199,169 1.003% 484,500 0.053%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit (USD)
US82481R1068 Purchase 100 166.08
US82481R1068 Purchase 200 166.33
US82481R1068 Sale 100 165.45
US82481R1068 Sale 200 165.51
US82481R1068 Sale 100 165.54
US82481R1068 Sale 100 165.81
US82481R1068 Sale 100 165.88
US82481R1068 Sale 200 165.90
US82481R1068 Sale 100 165.91
US82481R1068 Sale 1,519 165.96
US82481R1068 Sale 600 165.99
US82481R1068 Sale 109 166.17
US82481R1068 Sale 200 166.22
US82481R1068 Sale 181 166.26
US82481R1068 Sale 91 166.49
US82481R1068 Sale 100 165.43
US82481R1068 Sale 100 165.44
US82481R1068 Sale 100 165.46
US82481R1068 Sale 100 165.51
US82481R1068 Sale 100 165.58
US82481R1068 Sale 507 165.60
US82481R1068 Sale 300 165.64
US82481R1068 Sale 100 165.68
US82481R1068 Sale 100 165.70
US82481R1068 Sale 2,077 165.74
US82481R1068 Sale 1,580 165.79
US82481R1068 Sale 620 165.82
US82481R1068 Sale 600 165.83
US82481R1068 Sale 1,200 165.84
US82481R1068 Sale 4,931 165.85
US82481R1068 Sale 500 165.86
US82481R1068 Sale 623 165.87
US82481R1068 Sale 313 165.88
US82481R1068 Sale 600 165.90
US82481R1068 Sale 300 165.92
US82481R1068 Sale 2,300 165.93
US82481R1068 Sale 4,077 165.94
US82481R1068 Sale 100 165.96
US82481R1068 Sale 100 165.97
US82481R1068 Sale 700 165.98
US82481R1068 Sale 100 166.04
US82481R1068 Sale 400 166.07
US82481R1068 Sale 400 166.09
US82481R1068 Sale 100 166.10
US82481R1068 Sale 500 166.11
US82481R1068 Sale 100 166.12
US82481R1068 Sale 200 166.13
US82481R1068 Sale 1,365 166.14
US82481R1068 Sale 600 166.15
US82481R1068 Sale 100 166.16
US82481R1068 Sale 500 166.17
US82481R1068 Sale 93 166.18
US82481R1068 Sale 368 166.19
US82481R1068 Sale 161 166.21
US82481R1068 Sale 1,400 166.23
US82481R1068 Sale 300 166.25
US82481R1068 Sale 1,712 166.26
US82481R1068 Sale 1,835 166.27
US82481R1068 Sale 1,693 166.28
US82481R1068 Sale 800 166.29
US82481R1068 Sale 400 166.30
US82481R1068 Sale 5,124 166.31
US82481R1068 Sale 300 166.32
US82481R1068 Sale 1,140 166.33
US82481R1068 Sale 200 166.34
US82481R1068 Sale 300 166.35
US82481R1068 Sale 200 166.36
US82481R1068 Sale 200 166.38
US82481R1068 Sale 3,015 166.39
US82481R1068 Sale 1,231 166.40
US82481R1068 Sale 300 166.41
US82481R1068 Sale 800 166.42
US82481R1068 Sale 100 166.43
US82481R1068 Sale 3,791 166.44
US82481R1068 Sale 3,300 166.45
US82481R1068 Sale 400 166.46
US82481R1068 Sale 900 166.48
US82481R1068 Sale 600 166.49
US82481R1068 Sale 3,542 166.52
US82481R1068 Sale 2,100 166.54
US82481R1068 Sale 609 166.55
US82481R1068 Sale 300 166.57
US82481R1068 Sale 3,100 166.58
US82481R1068 Sale 101 166.60
US82481R1068 Sale 300 166.61
US82481R1068 Sale 5,000 166.62
US82481R1068 Sale 200 166.64
US82481R1068 Sale 1,800 166.65
US82481R1068 Sale 300 166.66
US82481R1068 Sale 1,261 166.67
US82481R1068 Sale 1,639 166.68
US82481R1068 Sale 410 166.69
US82481R1068 Sale 2 166.71
US82481R1068 Sale 100 166.77
US82481R1068 Sale 198 166.81
US82481R1068 Sale 100 166.88
US82481R1068 Sale 100 166.90
US82481R1068 Sale 100 166.91
US82481R1068 Purchase 163 165.41
US82481R1068 Purchase 63 165.42
US82481R1068 Purchase 100 165.43
US82481R1068 Purchase 200 165.45
US82481R1068 Purchase 415 165.46
US82481R1068 Purchase 500 165.47
US82481R1068 Purchase 300 165.48
US82481R1068 Purchase 649 165.49
US82481R1068 Purchase 1,985 165.50
US82481R1068 Purchase 70 165.51
US82481R1068 Purchase 200 165.53
US82481R1068 Purchase 100 165.55
US82481R1068 Purchase 100 165.56
US82481R1068 Purchase 251 165.57
US82481R1068 Purchase 300 165.58
US82481R1068 Purchase 600 165.59
US82481R1068 Purchase 100 165.62
US82481R1068 Purchase 100 165.65
US82481R1068 Purchase 100 165.68
US82481R1068 Purchase 200 165.70
US82481R1068 Purchase 100 165.71
US82481R1068 Purchase 36 165.72
US82481R1068 Purchase 50 165.75
US82481R1068 Purchase 100 165.76
US82481R1068 Purchase 100 165.82
US82481R1068 Purchase 200 165.84
US82481R1068 Purchase 100 165.85
US82481R1068 Purchase 103 165.86
US82481R1068 Purchase 200 165.88
US82481R1068 Purchase 200 165.89
US82481R1068 Purchase 167 165.91
US82481R1068 Purchase 200 165.92
US82481R1068 Purchase 3,500 165.93
US82481R1068 Purchase 100 165.94
US82481R1068 Purchase 100 165.96
US82481R1068 Purchase 200 165.98
US82481R1068 Purchase 101 166.00
US82481R1068 Purchase 100 166.01
US82481R1068 Purchase 200 166.04
US82481R1068 Purchase 100 166.06
US82481R1068 Purchase 100 166.07
US82481R1068 Purchase 232 166.08
US82481R1068 Purchase 100 166.09
US82481R1068 Purchase 4 166.10
US82481R1068 Purchase 100 166.11
US82481R1068 Purchase 361 166.12
US82481R1068 Purchase 400 166.16
US82481R1068 Purchase 200 166.17
US82481R1068 Purchase 100 166.18
US82481R1068 Purchase 100 166.19
US82481R1068 Purchase 200 166.20
US82481R1068 Purchase 200 166.22
US82481R1068 Purchase 300 166.23
US82481R1068 Purchase 404 166.24
US82481R1068 Purchase 300 166.25
US82481R1068 Purchase 733 166.27
US82481R1068 Purchase 530 166.28
US82481R1068 Purchase 549 166.29
US82481R1068 Purchase 3,737 166.30
US82481R1068 Purchase 446 166.31
US82481R1068 Purchase 200 166.32
US82481R1068 Purchase 159 166.33
US82481R1068 Purchase 200 166.34
US82481R1068 Purchase 200 166.35
US82481R1068 Purchase 100 166.36
US82481R1068 Purchase 100 166.37
US82481R1068 Purchase 400 166.39
US82481R1068 Purchase 638 166.40
US82481R1068 Purchase 200 166.41
US82481R1068 Purchase 300 166.42
US82481R1068 Purchase 300 166.43
US82481R1068 Purchase 100 166.44
US82481R1068 Purchase 170 166.45
US82481R1068 Purchase 358 166.46
US82481R1068 Purchase 300 166.47
US82481R1068 Purchase 200 166.48
US82481R1068 Purchase 300 166.49
US82481R1068 Purchase 300 166.50
US82481R1068 Purchase 100 166.51
US82481R1068 Purchase 100 166.52
US82481R1068 Purchase 100 166.53
US82481R1068 Purchase 1,159 166.54
US82481R1068 Purchase 400 166.55
US82481R1068 Purchase 300 166.56
US82481R1068 Purchase 400 166.57
US82481R1068 Purchase 100 166.58
US82481R1068 Purchase 400 166.59
US82481R1068 Purchase 300 166.60
US82481R1068 Purchase 100 166.61
US82481R1068 Purchase 200 166.62
US82481R1068 Purchase 1,800 166.63
US82481R1068 Purchase 100 166.64
US82481R1068 Purchase 100 166.66
US82481R1068 Purchase 200 166.67
US82481R1068 Purchase 200 166.70
US82481R1068 Purchase 100 166.71
US82481R1068 Purchase 300 166.72
US82481R1068 Purchase 100 166.73
US82481R1068 Purchase 20 166.74
US82481R1068 Purchase 601 166.75
US82481R1068 Purchase 1,000 166.76
US82481R1068 Purchase 300 166.77
US82481R1068 Purchase 100 166.78
US82481R1068 Purchase 100 166.80
US82481R1068 Purchase 200 166.81
US82481R1068 Purchase 200 166.82
US82481R1068 Purchase 200 166.83
US82481R1068 Purchase 200 166.86
US82481R1068 Purchase 200 166.87
US82481R1068 Purchase 150 166.88
US82481R1068 Purchase 100 166.89
US82481R1068 Purchase 50 166.90
US82481R1068 Purchase 100 167.07
US82481R1068 Purchase 100 167.12
US82481R1068 Sale 89 165.56
US82481R1068 Sale 41 165.91
US82481R1068 Sale 39 165.96
US82481R1068 Sale 40 166.22
US82481R1068 Sale 181 166.43
US82481R1068 Sale 200 166.45
US82481R1068 Sale 100 166.46
US82481R1068 Sale 851 166.87
US82481R1068 Sale 249 166.89
US82481R1068 Sale 300 166.90
US82481R1068 Sale 2,500 166.91
US82481R1068 Sale 1,000 166.92
US82481R1068 Sale 200 166.93
US82481R1068 Sale 900 166.94
US82481R1068 Sale 700 166.97
US82481R1068 Sale 700 166.98
US82481R1068 Sale 500 167.00
US82481R1068 Sale 200 167.01
US82481R1068 Sale 200 167.02
US82481R1068 Sale 500 167.03
US82481R1068 Sale 200 167.04
US82481R1068 Sale 900 167.11
US82481R1068 Sale 100 167.12

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit(GBP)
JE00B2QKY057 CFD Closing a long position 4,844 45.42
JE00B2QKY057 CFD Increasing a long position 542 43.84
JE00B2QKY057 CFD Opening a long position 1,123,024 45.33
JE00B2QKY057 CFD Increasing a long position 79,032 43.72
JE00B2QKY057 CFD Increasing a long position 20,599 43.80
JE00B2QKY057 CFD Increasing a long position 793 43.56
JE00B2QKY057 CFD Increasing a long position 3,442 43.83
JE00B2QKY057 CFD Reducing a long position 1,780 43.66
JE00B2QKY057 CFD Reducing a long position 12,467 43.76
JE00B2QKY057 CFD Reducing a long position 2,572 43.74
JE00B2QKY057 CFD Closing a long position 1,123,024 45.33

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

NONE

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

NONE

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 19th December 2018
Contact name: Milos Naumovic
Telephone number: +44 203 650 8203

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Full name of person making disclosure: Millennium International Management LP
Name of offeror/offeree in relation to whose relevant securities the disclosure relates: Shire plc

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security Product description e.g. call option Written or purchased Number of securities to which option or derivative relates Exercise price per unit Type

e.g. American, European etc.

Expiry date
US82481R1068 Call Option Purchased 360,000 180

USD

American 18.1.2019
US82481R1068 Put Option Purchased 120,000 4,200 GBP American 21.12.2018
US82481R1068 Call Option Purchased 120,000 4,400GBP American 15.3.2019
US82481R1068 Put Option Purchased 120,000 4,800GBP American 15.3.2019
US82481R1068 Call Option Purchased 250,000 5,200GBP American 18.1.2018
US82481R1068 Call Option Purchased 180,000 190 USD American 21.12.2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181219005490/en/

Copyright Business Wire 2018

Date   Source Headline
8th Jan 20195:30 pmGNWDirector/PDMR Shareholding
8th Jan 20193:20 pmRNSForm 8.3 - Shire plc
8th Jan 20193:19 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20193:13 pmRNSForm 8.3 - Shire plc
8th Jan 20193:07 pmRNSForm 8.5 (EPT/NON-RI)
8th Jan 20192:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20192:21 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
8th Jan 20191:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20191:27 pmRNSForm 8.3 - Shire plc
8th Jan 201912:31 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201912:29 pmRNSForm 8.3 - Takeda Pharmaceutical
8th Jan 201912:27 pmRNSForm 8.3 - Shire plc
8th Jan 201911:42 amRNSForm 8.5 (EPT/NON-RI)
8th Jan 201911:33 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
8th Jan 201910:49 amRNSForm 8.5 (EPT/RI)
8th Jan 201910:41 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 201910:26 amRNSForm 8.5 (EPT/RI)- Shire plc
8th Jan 20199:51 amRNSForm 8.3 - Shire Plc
8th Jan 20198:44 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
8th Jan 20197:00 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
8th Jan 20197:00 amGNWScheme becomes effective
7th Jan 20195:00 pmGNWHolding(s) in Company
7th Jan 20193:42 pmRNSForm 8.5 (EPT/RI) - Amendment
7th Jan 20193:20 pmRNSForm 8.3 - Shire plc
7th Jan 20193:02 pmRNSForm 8.3 - Shire plc
7th Jan 20193:00 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 20193:00 pmRNSForm 8.3 - Shire plc
7th Jan 20192:59 pmRNSForm 8.3 - Takeda Pharmaceutical
7th Jan 20192:50 pmPRNForm 8.3 - Shire Plc
7th Jan 20192:49 pmRNSForm 8.3 - Shire plc
7th Jan 20192:47 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20192:45 pmBUSForm 8.3 - Shire plc
7th Jan 20191:55 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 20191:54 pmRNSForm 8.3 - Shire plc
7th Jan 20191:39 pmRNSForm 8.3 - [Shire Plc]
7th Jan 20191:32 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 20191:29 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire
7th Jan 201912:57 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201912:56 pmRNSForm 8.3 - Shire plc
7th Jan 201912:42 pmRNSForm 8.5 (EPT/NON-RI)
7th Jan 201911:52 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:43 amBUSForm 8.3 - SHIRE PLC
7th Jan 201911:30 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
7th Jan 201911:27 amRNSForm 8.3 - Shire plc
7th Jan 201911:01 amRNSForm 8.5 (EPT/RI)- Shire plc
7th Jan 201910:59 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
7th Jan 201910:35 amRNSForm 8.5 - Shire plc
7th Jan 201910:16 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
7th Jan 201910:13 amRNSForm 8.5 (EPT/RI) - Amendment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.